{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:37:43Z","timestamp":1784763463582,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA028994"],"award-info":[{"award-number":["DA028994"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32-AI007386"],"award-info":[{"award-number":["T32-AI007386"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01-AI35039"],"award-info":[{"award-number":["U01-AI35039"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01-AI35040"],"award-info":[{"award-number":["U01-AI35040"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01-AI35041"],"award-info":[{"award-number":["U01-AI35041"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01-AI35042"],"award-info":[{"award-number":["U01-AI35042"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1-AI35043"],"award-info":[{"award-number":["UM1-AI35043"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR001102"],"award-info":[{"award-number":["UL1 TR001102"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1-TR000424"],"award-info":[{"award-number":["UL1-TR000424"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s10552-017-0896-9","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T06:47:08Z","timestamp":1493275628000},"page":"767-777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study"],"prefix":"10.1007","volume":"28","author":[{"given":"Anupriya","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Uno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Holman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Gabuzda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,27]]},"reference":[{"issue":"Suppl 23","key":"896_CR1","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1002\/cncr.29052","volume":"120","author":"MJ Schymura","year":"2014","unstructured":"Schymura MJ, Sun L, Percy-Laurry A (2014) Prostate cancer collaborative stage data items\u2014their definitions, quality, usage, and clinical implications: a review of SEER data for 2004\u20132010. Cancer 120(Suppl 23):3758\u20133770","journal-title":"Cancer"},{"key":"896_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/QAD.0000000000000163","volume":"28","author":"HA Robbins","year":"2014","unstructured":"Robbins HA, Shiels MS, Pfeiffer RM, Engels EA (2014) Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States. AIDS 28:881\u2013890","journal-title":"AIDS"},{"key":"896_CR3","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","volume":"33","author":"AE Coghill","year":"2015","unstructured":"Coghill AE, Shiels MS, Suneja G, Engels EA (2015) Elevated cancer-specific mortality among HIV-infected patients in the United States. J Clin Oncol 33:2376\u20132383","journal-title":"J Clin Oncol"},{"key":"896_CR4","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/MLR.0b013e31817d697f","volume":"46","author":"KC Heslin","year":"2008","unstructured":"Heslin KC, Gore JL, King WD, Fox SA (2008) Sexual orientation and testing for prostate and colorectal cancers among men in California. Med Care 46:1240\u20131248","journal-title":"Med Care"},{"key":"896_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.urology.2014.09.054","volume":"85","author":"DJ Riedel","year":"2015","unstructured":"Riedel DJ, Cox ER, Stafford KA, Gilliam BL (2015) Clinical presentation and outcomes of prostate cancer in an urban cohort of predominantly African American, human immunodeficiency virus-infected patients. Urology 85:415\u2013421","journal-title":"Urology"},{"key":"896_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3322\/caac.21340","volume":"66","author":"CE DeSantis","year":"2016","unstructured":"DeSantis CE, Siegel RL, Sauer AG et al (2016) Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J Clin 66:290\u2013308","journal-title":"CA Cancer J Clin"},{"key":"896_CR7","first-page":"4497","volume":"58","author":"RK Ross","year":"1998","unstructured":"Ross RK, Pike MC, Coetzee GA et al (1998) Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res 58:4497\u20134504","journal-title":"Cancer Res"},{"key":"896_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1158\/1055-9965.EPI-11-0727","volume":"21","author":"L Hughes","year":"2012","unstructured":"Hughes L, Zhu F, Ross E et al (2012) Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection. Cancer Epidemiol Biomark Prev 21:53\u201360","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"896_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/QAI.0000000000000202","volume":"66","author":"JL Marcus","year":"2014","unstructured":"Marcus JL, Chao CR, Leyden WA et al (2014) Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr 66:495\u2013502","journal-title":"J Acquir Immune Defic Syndr"},{"key":"896_CR10","doi-asserted-by":"crossref","first-page":"s843","DOI":"10.1093\/ajcn\/86.3.843S","volume":"86","author":"AW Hsing","year":"2007","unstructured":"Hsing AW, Sakoda LC, Chua S Jr (2007) Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 86:s843\u2013s857","journal-title":"Am J Clin Nutr"},{"key":"896_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/pcan.2008.44","volume":"12","author":"J Silberstein","year":"2009","unstructured":"Silberstein J, Downs T, Lakin C, Kane CJ (2009) HIV and prostate cancer: a systematic review of the literature. Prostate Cancer Prostatic Dis 12:6\u201312","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"896_CR12","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1158\/1055-9965.EPI-10-0741","volume":"19","author":"MS Shiels","year":"2010","unstructured":"Shiels MS, Goedert JJ, Moore RD, Platz EA, Engels EA (2010) Reduced risk of prostate cancer in U.S. Men with AIDS. Cancer Epidemiol Biomark Prev 19:2910\u20132915","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"896_CR13","first-page":"dju503","volume":"107","author":"HA Robbins","year":"2015","unstructured":"Robbins HA, Pfeiffer RM, Shiels MS, Li J, Hall HI, Engels EA (2015) Excess cancers among HIV-infected people in the United States. J Natl Cancer Inst 107:dju503","journal-title":"J Natl Cancer Inst"},{"key":"896_CR14","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1158\/1055-9965.EPI-11-0777","volume":"20","author":"MJ Silverberg","year":"2011","unstructured":"Silverberg MJ, Chao C, Leyden WA et al (2011) HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomark Prev 20:2551\u20132559","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"896_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/QAI.0b013e3181b033ab","volume":"52","author":"RJ Bedimo","year":"2009","unstructured":"Bedimo RJ, McGinnis KA, Dunlap M, Rodriguez-Barradas MC, Justice AC (2009) Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr 52:203\u2013208","journal-title":"J Acquir Immune Defic Syndr"},{"key":"896_CR16","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/cncr.21334","volume":"104","author":"A Burgi","year":"2005","unstructured":"Burgi A, Brodine S, Wegner S et al (2005) Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer 104:1505\u20131511","journal-title":"Cancer"},{"key":"896_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/cncr.20389","volume":"101","author":"NF Crum","year":"2004","unstructured":"Crum NF, Spencer CR, Amling CL (2004) Prostate carcinoma among men with human immunodeficiency virus infection. Cancer 101:294\u2013299","journal-title":"Cancer"},{"key":"896_CR18","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/aje\/kwm017","volume":"165","author":"NA Hessol","year":"2007","unstructured":"Hessol NA, Pipkin S, Schwarcz S, Cress RD, Bacchetti P, Scheer S (2007) The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol 165:1143\u20131153","journal-title":"Am J Epidemiol"},{"key":"896_CR19","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/j.1464-410X.2008.07474.x","volume":"101","author":"L Pantanowitz","year":"2008","unstructured":"Pantanowitz L, Bohac G, Cooley TP, Aboulafia D, Dezube BJ (2008) Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study. BJU Int 101:1519\u20131523","journal-title":"BJU Int"},{"key":"896_CR20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/00002030-199606001-00018","volume":"10","author":"JD Schwartz","year":"1996","unstructured":"Schwartz JD, Prince D (1996) Prostate cancer in HIV infection. AIDS 10:797\u2013798","journal-title":"AIDS"},{"key":"896_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/COH.0000000000000327","volume":"12","author":"MS Shiels","year":"2017","unstructured":"Shiels MS, Engels EA (2017) Evolving epidemiology of HIV-associated malignancies. Curr Opin HIV AIDS 12:6\u201311","journal-title":"Curr Opin HIV AIDS"},{"key":"896_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1056\/NEJMoa1110000","volume":"366","author":"CM Ewing","year":"2012","unstructured":"Ewing CM, Ray AM, Lange EM et al (2012) Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med 366:141\u2013149","journal-title":"N Engl J Med"},{"key":"896_CR23","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1002\/cncr.24324","volume":"115","author":"DW Lin","year":"2009","unstructured":"Lin DW, Porter M, Montgomery B (2009) Treatment and survival outcomes in young men diagnosed with prostate cancer: a population-based cohort study. Cancer 115:2863\u20132871","journal-title":"Cancer"},{"key":"896_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ucl.2009.11.004","volume":"37","author":"A Shteynshlyuger","year":"2010","unstructured":"Shteynshlyuger A, Andriole GL (2010) Prostate cancer: to screen or not to screen? Urol Clin N Am 37:1\u20139","journal-title":"Urol Clin N Am"},{"key":"896_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrurol.2014.91","volume":"11","author":"CA Salinas","year":"2014","unstructured":"Salinas CA, Tsodikov A, Ishak-Howard M, Cooney KA (2014) Prostate cancer in young men: an important clinical entity. Nat Rev Urol 11:317\u2013323","journal-title":"Nat Rev Urol"},{"key":"896_CR26","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1158\/1055-9965.EPI-13-1328","volume":"23","author":"IJ Powell","year":"2014","unstructured":"Powell IJ, Vigneau FD, Bock CH, Ruterbusch J, Heilbrun LK (2014) Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men. Cancer Epidemiol Biomark Prev 23:1505\u20131511","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"896_CR27","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1158\/1055-9965.EPI-14-0614","volume":"23","author":"AB Murphy","year":"2014","unstructured":"Murphy AB, Bhatia R, Martin IK et al (2014) Are HIV-infected men vulnerable to prostate cancer treatment disparities? Cancer Epidemiol Biomark Prev 23:2009\u20132018","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"896_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1089\/lgbt.2016.0029","volume":"3","author":"BR Simon Rosser","year":"2016","unstructured":"Simon Rosser BR, Merengwa E, Capistrant BD, Iantaffi A, Kilian G, Kohli N, Konety BR, Mitteldorf D, West W (2016) Prostate cancer in gay, bisexual, and other men who have sex with men: a review. LGBT Health 3:243","journal-title":"LGBT Health"},{"key":"896_CR29","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/ije\/dyu092","volume":"44","author":"JT Becker","year":"2014","unstructured":"Becker JT, Kingsley LA, Molsberry S et al (2014) Cohort profile: recruitment cohorts in the neuropsychological substudy of the multicenter AIDS cohort study. Int J Epidemiol 44:1506\u20131516","journal-title":"Int J Epidemiol"},{"key":"896_CR30","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1002\/cncr.25530","volume":"116","author":"EC Seaberg","year":"2010","unstructured":"Seaberg EC, Wiley D, Martinez-Maza O et al (2010) Cancer incidence in the multicenter AIDS cohort study before and during the HAART era: 1984 to 2007. Cancer 116:5507\u20135516","journal-title":"Cancer"},{"key":"896_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1542\/peds.2013-2768","volume":"133","author":"AJ Blashill","year":"2014","unstructured":"Blashill AJ, Safren SA (2014) Sexual orientation and anabolic-androgenic steroids in U.S. adolescent boys. Pediatrics 133:469\u2013475","journal-title":"Pediatrics"},{"key":"896_CR32","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1001\/archinternmed.2010.253","volume":"170","author":"EP Simard","year":"2010","unstructured":"Simard EP, Pfeiffer RM, Engels EA (2010) Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med 170:1337\u20131345","journal-title":"Arch Intern Med"},{"key":"896_CR33","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1097\/QAD.0b013e32835935b3","volume":"26","author":"C Chao","year":"2012","unstructured":"Chao C, Leyden WA, Xu L et al (2012) Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS 26:2223\u20132231","journal-title":"AIDS"},{"key":"896_CR34","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/jnci\/djg009","volume":"95","author":"E Giovannucci","year":"2003","unstructured":"Giovannucci E, Rimm EB, Liu Y et al (2003) Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst 95:1240\u20131244","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 1","key":"896_CR35","first-page":"S29","volume":"5","author":"MK Brawer","year":"2003","unstructured":"Brawer MK (2003) Androgen supplementation and prostate cancer risk: strategies for pretherapy assessment and monitoring. Rev Urol 5(Suppl 1):S29\u2013S33","journal-title":"Rev Urol"},{"key":"896_CR36","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/pros.22699","volume":"73","author":"AB Murphy","year":"2013","unstructured":"Murphy AB, Akereyeni F, Nyame YA et al (2013) Smoking and prostate cancer in a multi-ethnic cohort. Prostate 73:1518\u20131528","journal-title":"Prostate"},{"key":"896_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/0092623X.2012.726697","volume":"40","author":"ME Hartman","year":"2014","unstructured":"Hartman ME, Irvine J, Currie KL et al (2014) Exploring gay couples\u2019 experience with sexual dysfunction after radical prostatectomy: a qualitative study. J Sex Marital Ther 40:233\u2013253","journal-title":"J Sex Marital Ther"},{"key":"896_CR38","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1111\/jsm.12598","volume":"11","author":"TL Hart","year":"2014","unstructured":"Hart TL, Coon DW, Kowalkowski MA et al (2014) Changes in sexual roles and quality of life for gay men after prostate cancer: challenges for sexual health providers. J Sex Med 11:2308\u20132317","journal-title":"J Sex Med"},{"key":"896_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1300\/J236v09n01_06","volume":"9","author":"G Perlman","year":"2005","unstructured":"Perlman G (2005) Prostate cancer, the group, and me. J Gay Lesbian Psychother 9:69\u201390","journal-title":"J Gay Lesbian Psychother"},{"key":"896_CR40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/lgbt.2015.0092","volume":"3","author":"BR Simon Rosser","year":"2016","unstructured":"Simon Rosser BR, Merengwa E, Capistrant BD et al (2016) Prostate cancer in gay, bisexual, and other men who have sex with men: a review. LGBT Health 3:32\u201341","journal-title":"LGBT Health"},{"key":"896_CR41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0022-5347(17)35617-3","volume":"150","author":"BS Carter","year":"1993","unstructured":"Carter BS, Bova GS, Beaty TH et al (1993) Hereditary prostate cancer: epidemiologic and clinical features. J Urol 150:797\u2013802","journal-title":"J Urol"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-017-0896-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0896-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0896-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T20:14:46Z","timestamp":1589660086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-017-0896-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["896"],"URL":"https:\/\/doi.org\/10.1007\/s10552-017-0896-9","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]},"assertion":[{"value":"23 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}